Geovax Labs (GOVX) traded down -5.83 % during a 24 hours period ending at 10:11 AM Central Europe on Tuesday 27th. One Geovax Labs stock can currently be bought for about USD 0.19 on popular exchanges. Current supply of Geovax Labs stocks is 9.1 mn. Geovax Labs has a current market capitalization of USD 1.9 mn and approximately USD 44 k worth of Geovax Labs was traded on exchanges in the last 24 hours. Since last month end, Geovax Labs has traded -43.93 % down. Simple moving average of last 200 days is at USD 1.32. The highest price of past 52 weeks was recorded at USD 15 on 10/29/2025. 52 weeks low was at USD 0.19 on 10/26/2026.

Here is how related stocks have performed in the past 24 hours:

  • Xcel Brands (XELB) traded down -0.03 % and now trades at USD 0.36. Xcel Brands has a market capitalisation of USD 2.1 mn.

  • Direct Communication Solutio (DCSX) traded flat 0 % and now trades at USD 0.91. Direct Communication Solutio has a market capitalisation of USD 2.3 mn.

  • Focus Universal (FCUV) traded up 3.96 % and now trades at USD 3.54. Current market capitalisation for Focus Universal is USD 2.2 mn.

  • Singularity Future Technolog (SGLY) traded down -7.89 % and now trades at USD 0.35. Current market capitalisation for Singularity Future Technolog is USD 2.1 mn.

  • Adagio Medical (ADGM) traded down -5.83 % and now trades at USD 0.1. Adagio Medical has a market capitalisation of USD 2.2 mn. Adagio Medical Holdings, Inc. filed a current report with the U.S. Securities and Exchange Commission on October 23, 2026, announcing a special meeting of its stockholders. The meeting addressed a proposal to amend the company’s certificate of incorporation to permit a reverse stock split. The proposal received majority approval, with a sizable portion of shareholders voting in favor. The filing also confirmed the company’s status as a listed issuer on Nasdaq under the ticker ADGM and noted its continued designation as an emerging growth company. No additional business actions or material events were disclosed in the report.

About Geovax Labs

GeoVax Labs Inc. is a biomedical company that specializes in developing, manufacturing, testing, conducting human trials, licensing, and commercializing human vaccines for diseases caused by HIV-1 (human immunodeficiency virus) [AIDS] and other infectious agents.